Update on Therapeutic Drug Monitoring of Beta-Lactam Antibiotics in Critically Ill Patients—A Narrative Review
Beta-lactam antibiotics remain one of the most preferred groups of antibiotics in critical care due to their excellent safety profiles and their activity against a wide spectrum of pathogens. The cornerstone of appropriate therapy with beta-lactams is to achieve an adequate plasmatic concentration o...
Main Authors: | Jan Stašek, Filip Keller, Veronika Kočí, Jozef Klučka, Eva Klabusayová, Ondřej Wiewiorka, Zuzana Strašilová, Miroslava Beňovská, Markéta Škardová, Jan Maláska |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-03-01
|
Series: | Antibiotics |
Subjects: | |
Online Access: | https://www.mdpi.com/2079-6382/12/3/568 |
Similar Items
-
Why We May Need Higher Doses of Beta-Lactam Antibiotics: Introducing the ‘Maximum Tolerable Dose’
by: Sofie A. M. Dhaese, et al.
Published: (2022-07-01) -
Impact of Beta-Lactam Target Attainment on Resistance Development in Patients with Gram-Negative Infections
by: Nicole F. Maranchick, et al.
Published: (2023-12-01) -
Microbiological, Clinical, and PK/PD Features of the New Anti-Gram-Negative Antibiotics: β-Lactam/β-Lactamase Inhibitors in Combination and Cefiderocol—An All-Inclusive Guide for Clinicians
by: Luigi Principe, et al.
Published: (2022-04-01) -
β-Lactam Dosing in Critical Patients: A Narrative Review of Optimal Efficacy and the Prevention of Resistance and Toxicity
by: João Gonçalves Pereira, et al.
Published: (2022-12-01) -
Prolonged administration of β-lactam antibiotics – a comprehensive review and critical appraisal
by: Michael Osthoff, et al.
Published: (2016-10-01)